Search

Your search keyword '"Martin A.J."' showing total 1,227 results

Search Constraints

Start Over You searched for: Author "Martin A.J." Remove constraint Author: "Martin A.J."
1,227 results on '"Martin A.J."'

Search Results

1. The Khartoum-Omdurman conurbation: a growing megacity at the confluence of the Blue and White Nile Rivers

2. Contributors

14. Site U1530

15. Expedition 376 summary

16. Expedition 376 methods

17. Depositional environments in the White Nile Valley during the last 300,000 years

18. Paving the way towards future-proofing our crops

19. Improving crop yield potential:Underlying biological processes and future prospects

20. CropBooster-P : Towards a roadmap for plant research to future-proof crops in Europe

21. Improving crop yield potential: Underlying biological processes and future prospects

22. Approaches and determinants to sustainably improve crop production

26. The River Nile: Evolution and Environment

27. 39MO Clinical evaluation of a low-coverage whole-genome test for homologous recombination deficiency detection in ovarian cancer

28. 33O PRIMA/ENGOT-OV26/GOG-3012 study: Long-term conditional PFS

29. 36MO Maintenance olaparib plus bevacizumab (bev) in patients (pts) with newly diagnosed advanced ovarian cancer (OC): 5-year (y) progression-free survival (PFS) by molecular subgroup in the PAOLA-1/ENGOT-ov25 trial

33. 176O Final overall survival (OS) results from the phase III PAOLA-1/ENGOT-ov25 trial evaluating maintenance olaparib (ola) plus bevacizumab (bev) in patients (pts) with newly diagnosed advanced ovarian cancer (AOC)

38. Reconstructing prehistoric environments in the Son and Belan valleys, north-central India: Retrospect and Prospect

39. A river flowing through a desert: late Quaternary environments in the Nile basin – current understanding and unresolved questions

40. 1589P Chronological pattern of venous thromboembolism (VTE) occurrence impacts in survival of pancreatic ductal adenocarcinoma (PDAC)

41. LBA29 Final overall survival (OS) results from the phase III PAOLA-1/ENGOT-ov25 trial evaluating maintenance olaparib (ola) plus bevacizumab (bev) in patients (pts) with newly diagnosed advanced ovarian cancer (AOC)

42. 615TiP NIRVANA-1: A multicentre randomized study comparing carboplatin-paclitaxel (CP) followed by niraparib (nira) to CP–bevacizumab (bev) followed by nira-bev in patients with FIGO stage III ovarian high-grade epithelial cancer and no residual disease after upfront surgery

43. 517O Overall survival (OS) at 7-year (y) follow-up (f/u) in patients (pts) with newly diagnosed advanced ovarian cancer (OC) and a BRCA mutation (BRCAm) who received maintenance olaparib in the SOLO1/GOG-3004 trial

44. 530P PRIMA/ENGOT-OV26/GOG-3012 study: Updated long-term PFS and safety

46. 531P Maintenance olaparib monotherapy in patients (pts) with platinum-sensitive relapsed ovarian cancer (PSR OC) without a germline BRCA1/BRCA2 mutation (non-gBRCAm): Final overall survival (OS) results from the OPINION trial

47. 579P A multicenter evaluation of a low pass whole genome sequencing-based solution for homologous recombination deficiency detection

Catalog

Books, media, physical & digital resources